DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment




Cardiology Homepage

The 2019 Heart Rhythm Society scientific sessions: advanced technology in electrophysiology Four key takeaways

New machine learning algorithm could decide who is best for heart failure treatment Could help prevent sudden death from heart failure

Philips teams with Medtronic on cryoablation treatment for atrial fibrillation Will form an integrated solution for cryoablation

Varian acquires CyberHeart, enters cardiac radioablation market Emerging technology could benefit treatment of irregular heartbeats

FDA gives thumbs-up for Biofourmis’ RhythmAnalytics AI Platform Provides automated interpretations of cardiac arrhythmias

Israeli researchers develop first 3D heart from patient's biological materials A first — complete with blood vessels, ventricles and cells

Using comic illustrations to support patient understanding of cardiac catheterization Making patients more satisfied, less anxious and more informed

Medical community finds ways to make TAVR safer for at-risk patients Improving outcomes with special procedures

New ultrasound tech could help detect pediatric congenital heart disease Visualizes structure and blood flow of babies' hearts

Mick Jagger resting after TAVR heart surgery The 75 year old rock star is reportedly recovering from the operation at New York Presbyterian

Boston Scientific's
ImageReady System

Boston Scientific gets FDA nod for suite of MR-conditional pacing products

by Lauren Dubinsky , Senior Reporter
Boston Scientific announced on Monday that it received FDA approval for a suite of MR-conditional pacing products for full-body 1.5T MR exams. Its ImageReady MR-Conditional Pacing System includes ACCOLADE MRI and ESSENTIO MRI pacemakers and its new INGEVITY MRI pacing leads.

"With this approval, we believe we have the devices that offer the most comprehensive set of options for patients who need pacing therapy," Dr. Ken Stein, chief medical officer of the rhythm management division at Boston Scientific, told HCB News. "Should patients need to undergo magnetic resonance imaging after being implanted with our newly approved system, they are assured their device will be safe for use during their scan."

Story Continues Below Advertisement


Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.

The INGEVITY MRI pacing leads are used to treat patients with a condition that causes the heart to beat too slowly called bradycardia. The leads include both active and passive fixation models, which marks the first time a passive fixation pacing lead is approved in the U.S. for patients undergoing MR exams.

The ImageReady System was approved after two global clinical trials proved its safety and efficacy. The INGEVITY trial was a prospective, non-randomized study that tested the leads in 1,036 patients with a single- or dual-chamber pacemaker.

The SAMURAI trial was a prospective, randomized study that tested the ImageReady System on 351 patients with a single- or dual-chamber pacemaker in an MR environment.

In the first trial, the INGEVITY MRI had no MR-related complications and very low rates of complications overall. The SAMURAI trial showed that the ImageReady System provides clinicians with reassurance that they are implanting pacemakers that are safe in an MR environment if their patients require an exam in the future.

When paired with the LATITUDE NXT Patient Management System, the ImageReady System allows physicians to receive patient information through customized alerts. The tool is able to improve survival in patients with pacemakers, according to a study from June 2015 published in the Journal of the American College of Cardiology.

Earlier this month, Medtronic received FDA approval for the world's smallest pacemaker, its Mica Transcatheter Pacing System. It's the first and only transcatheter pacing system that is approved for both 1.5 and 3T full-body MR exams.

In recent years, an increasing amount of MR-conditional pacemakers and intravenous cardioverter defibrillators (ICDs) have entered the market. In DOTmed HCB News' March issue, we will explore MR-conditional ICDs in more depth.

Boston Scientific is actively pursuing MR compatibility for its approved ICD and cardiac resynchronization therapy (CRT) systems through its global ENABLE MRI study, which was started earlier this year. The findings of the study will be submitted to regulatory agencies in Asia and the U.S.

"Overall, we are very pleased to have this system now approved in the U.S.," said Stein. "In Europe, we have a full portfolio of devices with MR-conditional approval and our intent is to get the same approvals in the U.S."

Cardiology Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2019, Inc.